(Q43873502)

27 November 2017

title

Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study (English)

1 reference

27 November 2017

4

1 reference

27 November 2017

M Paulussen

1

1 reference

27 November 2017

S Ahrens

2

1 reference

27 November 2017

M Lehnert

3

1 reference

27 November 2017

H W Hense

5

1 reference

27 November 2017

A Wagner

6

1 reference

27 November 2017

J Dunst

7

1 reference

27 November 2017

D Harms

8

1 reference

27 November 2017

A Reiter

9

1 reference

27 November 2017

G Henze

10

1 reference

27 November 2017

C Niemeyer

11

1 reference

27 November 2017

U Göbel

12

1 reference

27 November 2017

B Kremens

13

1 reference

27 November 2017

U R Fölsch

14

1 reference

27 November 2017

W E Aulitzky

15

1 reference

27 November 2017

P A Voûte

16

1 reference

27 November 2017

A Zoubek

17

1 reference

27 November 2017

H Jürgens

18

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

1619-1630

1 reference

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Bone sarcomas linked to radiotherapy and chemotherapy in children

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

"Secondary cancers after Ewing sarcoma and Ewing sarcoma as second malignant neoplasm"

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Small-cell pediatric tumors: histology, immunohistochemistry, and electron microscopy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Improved methodology for analyzing local and distant recurrence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

A stand-alone windows applications for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Multiple primary neoplasms in childhood: data from the German Children's Cancer Registry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Secondary malignancies after bone marrow transplantation in adults

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013148730966

7 January 2021

Identifiers

DOI

10.1023/A:1013148730966

1 reference

27 November 2017

1 reference